Overall verdict
Neutral
4.3/10
1-year performance
+17.75%
Score breakdown
Up 17.7% over 1 year, 51% of the 52-week range.
Strongest: Financial strength 9.0/10. Weakest: Valuation 0.1/10.
Linde India Limited manufactures and sells industrial and medical gases in India and internationally. It operates through Gases, Related Products and Services; and Project Engineering Division segments. It supplies oxygen, nitrogen, and argon gases through onsite pipeline systems, bulk liquid distribution networks, and packaged gas solutions.
The company also engages in manufacture of industrial and medical gases and construction of cryogenic and non-cryogenic air separation plants. It serves various industries, such as steel, automotive, pharma, metal fabrication, chemicals, food and beverage, solar panels, science and research, natural gas and oil refining, petrochemicals, fertilizers, electronics, and metal processing, as well as hospitals and healthcare establishments.
The company was formerly known as BOC India Limited and changed its name to Linde India Limited in February 2013. Linde India Limited was incorporated in 1935 and is based in Kolkata, India. Linde India Limited is a subsidiary of The BOC Group Limited.
Sector
Materials
Industry
Chemicals
Primary listing
Nse
India
CEO
Milan Sadhukhan
Founded
1935
Employees
2 419
Revenue / employee
10.5M INR
Next earnings
February 2, 2027 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
8042.70 INR
52-week low
5538.60 INR
1-year performance
17.75%
Rising
Year-to-date performance
14.65%
Rising
Drawdown
-15.40%
Marked drawdown
Position in the 52-week range
51% of range
Gross margin 46.2%, net margin 18.1%, ROIC 10.5%, ROE 11.8%.
Net margin
18.08%
Exceptional
Sector 10.10%|S&P 13.40%
Gross margin
46.18%
High
Return on equity (ROE)
11.79%
Fair
Sector 9.93%|S&P 17.06%
Return on invested capital (ROIC)
10.46%
Exceptional
Free cash flow margin (FCF)
-56.78%
Negative
Profit-to-cash conversion (FCF conversion)
-3.14x
Low
Margin stability
4.2 pts
Steady
Revenue to net income
Growth
3.3/10Revenue up 12.3% over 1 year, 11.5% a year over 5, EPS 29.4% a year over 5.
Revenue (trailing 12 months)
26.6Md INR
Revenue growth (1y)
12.26%
Solid
Revenue growth (3y)
0.94%
Moderate
EPS growth (1y)
20.69%
Solid
EPS CAGR (5y)
29.44%
Exceptional
EPS revisions (3 months)
—
Valuation
0.1/10P/E 117.4x, forward P/E 105.2x, EV/EBITDA 70.3x, PEG 3.99. The multiple sits in the 49th percentile of its own 5-year history.
P/E (TTM)
117.4x
Expensive
Sector 69.8x|S&P 23.6x
Forward P/E
105.2x
Very expensive
EV / EBITDA
70.3x
Very expensive
Sector 14.3x|S&P 15.5x
PEG
3.99
Very expensive
Sector 0.55|S&P 0.91
P/E vs its own 5-year history
among the 49% lowest valuations
In line with its history
Market cap
582Md INR
Financial strength
9.0/10Cash covers 20.1% of the debt, net debt/EBITDA -0.0x.
Net debt / EBITDA
-0.0x
Very solid
Gearing (net debt / equity)
18.69%
Very solid
Cash
2.0Md INR
Cash / market cap
0.35%
Stretched
Cash / total debt
20.09%
Tight
Interest coverage
20.4x
Very solid
Net debt
8.0Md INR
Equity
42.7Md INR
Closed daily candles, 2 years
Last close on November 11, 2026: 6,821.95 INR
- MM206,082.66
- MM506,160.35
- MM2006,733.44
- RSI 1469.4
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.18%
200-day average slope, 3 months
+1.48%
50-day average slope, 1 month
-4.62%
Price structure
Lower lows
Bullish RSI divergence
Yes
20-day volatility
3.20 % per day
Volatility change
+107.44%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 64.70 (2) | 64.70 (2) | 29 660 (2) | 10 638 (2) | 5 521 (2) |
Amounts in millions of INR, EPS in INR per share. In brackets, the number of analysts. Consensus as of November 4, 2026.
Same sub-industry: 20 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LIN | 6.5 | 6.0 | 242Md USD | 35.0x | 19.3 % | 9.2 % | 12.0 % | 1.8x | 2.1 % | 28.1 % | ||
| 2 | 4091 | 6.5 | 6.9 | 16.1Md USD | 18.0x | 10.1 % | 11.7 % | 7.8 % | 2.4x | 5.8 % | 21.7 % | ||
| 3 | 002430 | 6.1 | 5.5 | 3.9Md USD | 21.2x | 6.9 % | 16.4 % | 7.5 % | 2.0x | 4.7 % | -8.0 % | ||
| 4 | AI | 5.3 | 4.4 | 134Md USD | 34.6x | 13.1 % | -0.4 % | 9.7 % | 1.2x | 1.3 % | 24.0 % | ||
| 5 | 688146 | 5.1 | 5.2 | 9.5Md USD | 114.2x | 20.2 % | 114.9 % | 11.7 % | -3.8x | 0.1 % | 273.0 % | ||
| 6 | SOL | 5.1 | 5.4 | 6.3Md USD | 33.3x | 9.4 % | 10.3 % | 9.6 % | 1.2x | 1.3 % | 28.6 % | ||
| 7 | 523457 | 4.3 | 4.0 | 6.2Md USD | 117.4x | 18.1 % | 12.3 % | 10.5 % | -0.0x | -2.6 % | 17.7 % | ||
| 8 | APD | 4.2 | 2.7 | 70.2Md USD | 132.3x | 4.1 % | 12.3 % | 1.7 % | 3.6x | 0.7 % | 21.5 % | ||
| 9 | 4088 | 4.0 | 3.6 | 4.0Md USD | Not meaningful (loss) | -5.7 % | 10.3 % | -8.0 % | 4.5x | 5.8 % | 23.8 % |
